Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 85 years old.
- People who have had sudden symptoms of neurological problems, such as weakness, numbness, or difficulty speaking.
- People whose neurological symptoms appear to be caused by a blocked blood vessel.
- People whose symptoms started no more than 24 hours before being enrolled in the trial.
- People who scored 6 or higher on a standard stroke severity assessment (called the NIHSS) before enrolment.
- People for whom the treating doctor has determined that the procedure and the required instruments can reach the affected area safely.
- People (or their legal guardians) who understand the purpose of the trial, agree to take part voluntarily, sign a written consent form, and are able to attend follow-up appointments.
- People confirmed by medical imaging (CTA, MRA, or DSA) to have a blockage in a specific large blood vessel at the front of the brain (the internal carotid artery or the M1 segment of the middle cerebral artery).
- People whose stroke symptoms have worsened due to a recurring blockage in the same area of the brain, or whose condition is caused by reduced blood flow to the brain.
Who may not be able to join:
- People who had significant disability before their stroke, as measured by a standard disability scale (mRS score greater than 1).
- People who have signs of a stroke affecting both sides of the brain, or both the front and back areas of the brain at the same time.
- People who scored 6 or below on the stroke severity assessment (NIHSS).
- People whose brain scans show a bleed in the brain or around it (cerebral or subarachnoid haemorrhage).
- People with active bleeding, severe anaemia, blood clotting problems, or certain abnormal blood test results (including low haemoglobin, low platelet count, or abnormal clotting measures), or a history of a specific type of low platelet count related to blood-thinning medication.
- People whose heart function is significantly reduced, or who have a known history of heart failure, and who the treating doctor believes are at higher risk of serious heart complications.
- People with severe heart, liver, or kidney disease.
- People with a serious illness such as advanced cancer where life expectancy is less than 3 months.
- People who are already taking part in another clinical trial, whether in the active treatment or follow-up phase.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 8613607548156
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients with modified Rankin Score 0-2 at 90 days.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.